Condition: Lung Cancer (Diagnosis) · Health Adult Subjects · Patient · Sponsor: Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
This research is a clinical performance study of in vitro diagnostic device (IVD), a prospective, multicentre, open-label, case-control clinical investigation aimed at constructing a predictive model that allows results to be classified as positive or negative in relation to the probability of having lung cancer.
This description comes directly from the study's public registry record.
Antonio Cubillo, MD · 917 56 79 97 · acubillo@hmhospitales.com
Paloma Peinado, MD · ppeinado@hmhospitales.com
Always discuss trial participation with your own doctor first.
| Hospital General Universitario de Elche | Elche, Alicante, Spain | Recruiting |
| Hospital del Mar | Barcelona, Barcelona, Spain | Recruiting |
| Institut Catalá D'Oncologia Badalona (ICO) | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Universitario Marqués de Valdecilla | Santander, Cantabria, Spain | Recruiting |
| Clínica Universidad de Navarra | Madrid, Madrid, Spain | Recruiting |
| HM Sanchinarro/CIOCC | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario 12 Octubre | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Clínico San Carlos | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Central de Asturias | Oviedo, Principality of Asturias, Spain | Recruiting |
| Complejo Hospitalario de Toledo | Toledo, Toledo, Spain | Recruiting |
| Hospital Universitari I Politècnic La Fe | Valencia, Valencia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07465848